Sarajane Ross
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 10
- MRI in cancer diagnosis 4
- Advanced MRI Techniques and Applications 4
- Oncology 15
- Cancer Cells and Metastasis 5
- HER2/EGFR in Cancer Research 4
- Co-authors
- Hartmut KoeppenFranklin PealeSharon YeeMaria S. RomeroPaul PolakisKlára TótpálAvi AshkenaziPhyllis Strickland
- Journals
- Cancer Research (12 papers)Magnetic Resonance in Medicine (3 papers)Molecular Cancer Therapeutics (2 papers)Cancer Cell (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Sarajane Ross
37 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 98
- Oncology 1.2k
- Radiology, Nuclear Medicine and Imaging 883
- Molecular Biology 2.0k
- Immunology 490
- Cancer Research 327
Countries citing papers authored by Sarajane Ross
This map shows the geographic impact of Sarajane Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarajane Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarajane Ross more than expected).
Fields of papers citing papers by Sarajane Ross
This network shows the impact of papers produced by Sarajane Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarajane Ross. The network helps show where Sarajane Ross may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarajane Ross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 20 | |
| 2 | 2014 | 52 | |
| 3 | 2014 | 15 | |
| 4 | 2013 | 17 | |
| 5 | 2011 | 11 | |
| 6 | 2009 | 197 | |
| 7 | 2008 | 171 | |
| 8 | Mechanistic evaluation of the combination effect of anti-VEGF and chemotherapy | 2008 | 3 |
| 9 | 2008 | 40 | |
| 10 | 2008 | 120 | |
| 11 | 2007 | 70 | |
| 12 | Activity of Apomab, a fully human agonistic DR5 monoclonal antibody, in models of non-Hodgkin’s lymphoma | 2007 | 3 |
| 13 | Armed antibodies targeted to STEAP1 inhibit growth of human prostate xenografts in vivo | 2007 | 1 |
| 14 | 2007 | 425 | |
| 15 | Evolution of the MDA-MB-175 breast cancer cell line from a low to a high HER2 expressing tumor line | 2005 | 1 |
| 16 | 2005 | 7 | |
| 17 | 2004 | 107 | |
| 18 | 2003 | 73 | |
| 19 | 2001 | 84 | |
| 20 | 2001 | 21 |
About Sarajane Ross
Sarajane Ross is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Immunology, Biotechnology and Molecular Biology, having authored 37 papers that have together received 3.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Cancer Cells and Metastasis (5 papers), Immunotherapy and Immune Responses (5 papers), Angiogenesis and VEGF in Cancer (5 papers), MRI in cancer diagnosis (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Advanced MRI Techniques and Applications (4 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Oncology (1.2k citations), Radiology, Nuclear Medicine and Imaging (883 citations), Molecular Biology (2.0k citations), Immunology (490 citations) and Cancer Research (327 citations). Sarajane Ross has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Hartmut Koeppen, Franklin Peale, Sharon Yee, Maria S. Romero, Paul Polakis, Klára Tótpál, Avi Ashkenazi, Phyllis Strickland, Wei‐Qiang Gao and Charles W. Daniel. Their work appears in journals such as Cancer Research, Magnetic Resonance in Medicine, Molecular Cancer Therapeutics, Cancer Cell and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.